Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $52.34 ($466K) on 2015-09-01, disclosed to the SEC on 2015-09-03.
Scheduled sale ($466k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.36 | 5,019 | $258K | 55.3% |
| 2 | $52.34 | 3,712 | $194K | 41.7% |
| 3 | $52.90 | 269 | $14K | 3.1% |
| Total | $51.81 avg | 9,000 | $466K | 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |